News Summary: New Alzheimer’s studies offer hope

Published



ALZHEIMER’S RESEARCH: Scientists at drugmakers including Merck, Eli Lilly and Roche are starting a new round of studies of potential drugs to treat or perhaps even prevent Alzheimer’s disease.

HOPE ON HORIZON: The Alzheimer’s Association’s top scientist says if the studies pan out, a medicine to slow or even stop progression of the mind-robbing disease could be ready in three to five years.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.